We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+1.69%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$19.6B
AUM Growth
-$1.32B
Cap. Flow
-$1.4B
Cap. Flow %
-7.16%
Top 10 Hldgs %
25.07%
Holding
1,468
New
83
Increased
502
Reduced
673
Closed
84

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$112M
2
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$77.7M
3
MSFT icon
Microsoft
MSFT
+$65.3M
4
MRK icon
Merck
MRK
+$61.7M
5
HD icon
Home Depot
HD
+$42.2M

Sector Composition

Rank Sector Weight
1 Technology 23.77%
2 Financials 10.7%
3 Healthcare 9.86%
4 Consumer Discretionary 9.05%
5 Industrials 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LW icon
1026
Lamb Weston
LW
$7.55B
$373K ﹤0.01%
5,581
+373
+7% +$27.8K
DBEF icon
1027
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.16B
$373K ﹤0.01%
9,000
EGP icon
1028
EastGroup Properties
EGP
$11.2B
$370K ﹤0.01%
2,308
+392
+20% +$67.7K
KBH icon
1029
KB Home
KBH
$3.56B
$370K ﹤0.01%
5,632
+53
+0.9% +$4.12K
ING icon
1030
ING
ING
$94.1B
$370K ﹤0.01%
23,586
-2,876
-11% -$46.7K
PRN icon
1031
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$401M
$367K ﹤0.01%
2,385
-51
-2% -$8.36K
CTRA
1032
DELISTED
Coterra Energy
CTRA
$365K ﹤0.01%
14,291
-4,754
-25% -$118K
MAGN
1033
Magnera Corp
MAGN
$492M
$364K ﹤0.01%
20,030
+2,138
+12% +$43.8K
NSSC icon
1034
Napco Security Technologies
NSSC
$1.33B
$362K ﹤0.01%
10,184
+1,019
+11% +$39.1K
BBIO icon
1035
BridgeBio Pharma
BBIO
$16.7B
$360K ﹤0.01%
13,119
-3,196
-20% -$82.6K
APTV icon
1036
Aptiv
APTV
$12.5B
$360K ﹤0.01%
5,946
+2,182
+58% +$134K
CENTA icon
1037
Central Garden & Pet Co Class A
CENTA
$2.41B
$358K ﹤0.01%
10,841
-3,717
-26% -$118K
SAIA icon
1038
Saia
SAIA
$10.7B
$356K ﹤0.01%
782
+130
+20% +$64.3K
AVB icon
1039
AvalonBay Communities
AVB
$27.4B
$353K ﹤0.01%
1,606
-1,000
-38% -$226K
MHK icon
1040
Mohawk Industries
MHK
$6.92B
$352K ﹤0.01%
2,956
+188
+7% +$26.3K
HRL icon
1041
Hormel Foods
HRL
$14.2B
$351K ﹤0.01%
11,178
+426
+4% +$13.4K
QEFA icon
1042
State Street SPDR MSCI EAFE StrategicFactors ETF
QEFA
$1.05B
$348K ﹤0.01%
4,796
+4,751
+10,558% +$363K
BCS icon
1043
Barclays
BCS
$88.7B
$347K ﹤0.01%
26,137
+5,093
+24% +$66K
SLP icon
1044
Simulations Plus
SLP
$372M
$347K ﹤0.01%
12,446
-555
-4% -$16.9K
BBWI icon
1045
Bath & Body Works
BBWI
$4.09B
$346K ﹤0.01%
8,934
-3,898
-30% -$130K
HLMN icon
1046
Hillman Solutions
HLMN
$1.57B
$346K ﹤0.01%
35,544
-3,140
-8% -$33.6K
PTGX icon
1047
Protagonist Therapeutics
PTGX
$8.73B
$346K ﹤0.01%
8,953
-6,028
-40% -$263K
CBZ icon
1048
CBIZ
CBZ
$2.92B
$345K ﹤0.01%
4,219
-206
-5% -$15.4K
CM icon
1049
Canadian Imperial Bank of Commerce
CM
$108B
$343K ﹤0.01%
5,422
-1,401
-21% -$89K
AMLP icon
1050
Alerian MLP ETF
AMLP
$13B
$342K ﹤0.01%
7,100

Similar funds

Glenmede Trust's Q4 2024 Portfolio in Review

As of Q4 2024, Glenmede Trust held 1,468 positions worth $19.6B, down 6.3% from $20.9B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Glenmede Trust withdrew a net $1.4B in Q4 2024, closing 84 positions and reducing 673 holdings. Its most notable exit was Primo Water Corporation, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Glenmede Trust opened a new position in Brink's worth $14.5M.

  • Glenmede Trust's largest Q4 2024 buy was Brink's: 156,825 shares worth $14.5M.
  • Glenmede Trust added most to iShares Russell 2500 ETF in Q4 2024, an estimated $99.1M increase.
  • Glenmede Trust's biggest Q4 2024 reduction was Apple, cutting an estimated $112M.
  • Glenmede Trust fully exited Primo Water Corporation in Q4 2024, selling an estimated $19.8M.
  • Glenmede Trust's ten largest holdings make up 25% of its $19.6B portfolio in Q4 2024.
  • Glenmede Trust opened 83 new positions and closed 84 in Q4 2024.
  • Glenmede Trust's portfolio value fell 6.3% quarter-over-quarter to $19.6B.

Based on Glenmede Trust's 13F filing for Q4 2024, filed 14 Feb 2025.